Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
389.14
299.15
283.23
133.68
239.47
308.33
214.97
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
389.14
299.15
283.23
133.68
239.47
308.33
214.97
Raw Material Cost
167.05
121.82
140.20
80.21
98.61
148.54
119.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.57
23.28
24.96
22.57
25.27
25.25
27.07
Selling and Distribution Expenses
27.74
33.45
58.20
55.63
26.71
45.36
70.53
Other Expenses
4.76
0.52
2.86
0.56
-0.73
-1.07
-0.17
Total Expenditure (Excl Depreciation)
259.96
183.73
251.97
163.97
143.31
208.47
215.81
Operating Profit (PBDIT) excl Other Income
129.2
115.39999999999999
31.299999999999997
-30.299999999999997
96.19999999999999
99.9
-0.8
Other Income
-2.78
2.01
0.92
-11.25
16.19
4.54
7.89
Operating Profit (PBDIT)
156.55
153.64
40.53
-15.12
142.65
135.14
-70.21
Interest
17.57
23.28
24.96
22.57
25.27
25.25
27.07
Exceptional Items
-0.08
-0.05
-0.00
-0.06
0.22
-0.00
0.00
Gross Profit (PBDT)
222.09
177.32
143.03
53.47
140.87
159.79
95.05
Depreciation
40.40
40.40
36.39
36.39
33.13
33.13
39.18
Profit Before Tax
98.50
89.91
-20.81
-74.13
84.48
76.76
-136.47
Tax
8.62
9.50
12.35
2.41
8.53
6.91
9.44
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
108.89
127.81
-34.78
-74.12
75.60
69.87
-138.85
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
108.89
127.81
-34.78
-74.12
75.60
69.87
-138.85
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.64
-0.42
-0.95
-0.64
-0.52
-0.43
-5.41
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
108.25
127.39
-35.73
-74.76
75.08
69.44
-144.26
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
850.24
741.56
613.95
649.15
723.77
648.40
578.63
Earnings per share (EPS)
0.12
0.14
-0.04
-0.08
0.09
0.08
-0.16
Diluted Earnings per share
0.12
0.14
-0.04
-0.08
0.09
0.08
-0.16
Operating Profit Margin (Excl OI)
30.56%
37.18%
1.14%
-30.11%
38.98%
31.61%
-54.56%
Gross Profit Margin
35.69%
43.56%
5.5%
-28.23%
49.11%
35.64%
-45.25%
PAT Margin
27.98%
42.73%
-12.28%
-55.44%
31.57%
22.66%
-64.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 30.09% vs 5.61% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -15.07% vs 456.86% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 5.08% vs 282.83% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -24.46% vs -6.80% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Hybio Pharmaceutical Co.. Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
389.14
0
389.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
389.14
0
389.14
Raw Material Cost
167.05
0
167.05
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
17.57
0
17.57
Selling and Distribution Expenses
27.74
0
27.74
Other Expenses
4.76
0.00
4.76
Total Expenditure (Excl Depreciation)
259.96
0
259.96
Operating Profit (PBDIT) excl Other Income
129.18
0.00
129.18
Other Income
-2.78
0
-2.78
Operating Profit (PBDIT)
156.55
0
156.55
Interest
17.57
0
17.57
Exceptional Items
-0.08
0
-0.08
Gross Profit (PBDT)
222.09
0
222.09
Depreciation
40.40
0
40.40
Profit Before Tax
98.50
0
98.50
Tax
8.62
0
8.62
Provisions and contingencies
0
0
0.00
Profit After Tax
108.89
0
108.89
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
108.89
0
108.89
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.64
0
-0.64
Other related items
0.00
0.00
0.00
Consolidated Net Profit
108.25
0
108.25
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
850.24
0
850.24
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
30.56%
0%
0.00
30.56%
Gross Profit Margin
35.69%
0%
0.00
35.69%
PAT Margin
27.98%
0%
0.00
27.98%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 38.91 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 30.09% vs 5.61% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 62.46% vs 133.89% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.82 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -15.07% vs 456.86% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 44.07% vs 2,108.82% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.93 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 5.08% vs 282.83% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 25.93% vs 685.71% in Jun 2025
Quarterly - Interest
Interest 1.76 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -24.46% vs -6.80% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -30.43% vs -6.30% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.56%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
